Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they plan to take to ensure that dementia is explicitly designed into the neighbourhood health model at a national level and to prevent local discretion and variable commissioning decisions in relation to such services.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
This Government is empowering local leaders with the autonomy they need to provide the best services to their local community, including those with dementia. This is why we have published the D100: Assessment Tool Pathway programme, which brings together multiple resources into a single, consolidated tool. This will help simplify best practice for system leaders and help create communities and services where the best possible care and support is available to those with dementia.
We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity, informed by phase one of the independent commission into adult social care, which is expected this year. The framework will seek to reduce unwarranted variation and narrow inequality for those living with dementia.
Neighbourhood Health provides the unifying framework that brings together what is already underway across primary care, community services, urgent care, prevention, digital, estates and population health into a single, coherent model focused on improved access, experience and outcomes.
Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they propose to take to support women with long-term health conditions.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The health of women with long-term conditions is a priority for the Government.
Our 10-Year Health Plan is centred around driving three shifts in the way health care is delivered, from hospital to community, from analogue to digital, and from sickness to prevention. More tests and scans are delivered in the community, better-joint up working between services, and greater use of technology will support women in the management of long-term conditions. This will build on the work led by the pioneering women’s health hubs.
The Government is encouraging integrated care boards (ICBs) to expand the coverage of women’s health hubs and is supporting them to use what we learned from the hub pilot programme to improve local delivery of services to women and girls. The Government is backing ICBs to do this through record funding.
We are renewing the Women’s Health Strategy, to tackle enduring challenges and build on vital progress in women’s health.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to discuss future plans for services for autistic people with (1) Ambitious about Autism, (2) Autistica, (3) Autism Action, (4) the National Autistic Society, and (5) Autism Alliance UK.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
We remain committed to working together across Government and with national autism charities to improve services and outcomes for autistic people.
On 23 January, we published our response to the House of Lords Autism Act 2009 Inquiry Committee’s report Time to deliver: The Autism Act 2009 and the new autism strategy. We are carefully considering the report’s recommendations as well as our approach to the national autism strategy and will set out a position, including our plans to engage with stakeholders, in due course.
Asked by: Lord Naseby (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they plan to set a target of 50 per cent of NHS doctors to be educated in the UK.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has no plans to set a specific target for the proportion of National Health Service doctors educated in the United Kingdom.
The Medical Training Prioritisation Bill, introduced to Parliament on 13 January 2026, delivers the Government’s commitment to prioritise UK medical graduates for foundation training places, and to prioritise UK medical graduates and other doctors with significant NHS experience for specialty training places. The bill will ensure a sustainable medical workforce that can meet the health needs of the future and give homegrown talent a path to become the next generation of NHS doctors.
Asked by: Lord Moylan (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what safeguards exist to prevent patients from losing access to established, life-extending cancer treatments as a result of changes to NICE methodology.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) evaluates all newly licensed cancer medicines and may recommend promising treatments for use through the Cancer Drugs Fund (CDF) where there is too much clinical uncertainty for routine commissioning. Under these arrangements, cancer medicines are made available to National Health Service patients for a defined period while further real‑world evidence is collected to address the uncertainties identified in NICE’s original appraisal.
At the end of the managed access period, NICE undertakes a full re‑appraisal of the medicine. This re‑appraisal considers all the evidence gathered during CDF use alongside updated clinical and cost‑effectiveness analyses. NICE then determines whether the medicine should be routinely funded by the NHS, or whether it cannot be recommended for routine commissioning. This re‑appraisal process is one of the limited circumstances in which NICE routinely re‑evaluates previous decisions.
In 2022, NICE updated its methods and replaced the earlier end‑of‑life flexibilities with the severity modifier. As a result, re‑appraisals of cancer medicines that originally entered the CDF under end‑of‑life criteria are now conducted in line with NICE’s current methods framework, ensuring consistency, fairness, and opportunity‑cost neutrality across all appraisals. NICE has recommended 96% of the medicines that it has re-appraised following a period of managed access for routine NHS use. Where NICE is unable to recommend a medicine for routine use following the period of managed access, it remains available for existing patients but is no longer routinely funded for new patients.
Asked by: Lord Bird (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what analysis they have undertaken of the distribution of healthcare professionals across regions; and how workforce planning reflects areas of greatest health needs.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
There are a range of sources that present data detailing how staff working in National Health Service roles are distributed across England. These published sources include, but are not limited to, information on the trust and region of staff employed by NHS trusts and integrated care boards, information on vacancies in the NHS, and information on general medical practice staff. This information is available on the NHS.UK website.
The forthcoming 10 Year Workforce Plan will set out further detail on how we will ensure the NHS has the right staff, in the right places, to deliver high quality care for patients when they need it.
Workforce planning for medical staff already means that Medical Foundation and Specialty training posts are allocated across the United Kingdom to support workforce needs, including in rural and hard to recruit areas. While some locations have historically found recruitment more challenging, we now have fewer vacancies in the Foundation Programme. NHS England is working with a number of medical schools to pilot the allocation of students directly to their local foundation schools.
Asked by: Lord Kamall (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of how the principles of the Armed Forces Covenant are being applied by (1) Op COMMUNITY, and (2) local health bodies.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
No formal assessment has been made to how the principles of the Armed Forces Covenant are being applied by Op COMMUNITY or local health bodies.
Op COMMUNITY was an NHS England funded pilot that concluded in March 2024. Insights from the pilot have been used to shape the new Armed Forces National Training and Education Programme, which aims to strengthen understanding across the National Health Service of the unique needs of the Armed Forces community.
The programme is now being rolled out across the NHS. Dedicated training modules for integrated care boards will be introduced in 2026. These will support local NHS staff in developing a clearer understanding of the specific health needs of the Armed Forces community and the principles underpinning the Armed Forces Covenant.
Asked by: Lord Kamall (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the cost-effectiveness of increasing the uptake of urine albumin-creatine ratio tests so that all patients with chronic kidney disease have an annual test.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department has not made a specific assessment. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing clinical guidance and quality standards. NICE’s guidance on chronic kidney disease includes guidance on the use of annual urine albumin-creatine ratio tests as the preferred method to detect and monitor kidney disease. The guidance is available on NICE’s website.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what proposals they intend to take forward in the 10 Year Health Plan for England in relation to services for autistic people.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The 10-Year Health Plan sets out to make the National Health Service fit for the future, by delivering three big shifts, from hospital to care in community, from analogue to digital, and from sickness to prevention. The plan will help to address health inequalities for disabled and autistic people by improving access to care, delivering care closer to home, and supporting the development of holistic care plans for those whose needs may require support from multiple health and care providers. We want autistic people’s access to, and experience of, healthcare services to be equitable, effective, and responsive to their needs.
The plan sets out the core principle of early intervention and support, including without the need for diagnosis, including specifically for children and young people, such as those with special educational needs and disabilities (SEND). It is clear about the importance of health services working in partnership with education settings and providing children and young people with early intervention and support to avoid needs escalating, where possible, building on learning from programmes such as Early Language Support for Every Child. We will set out our proposals for SEND reform in the upcoming Schools White Paper.
NHS England continues to support local systems to use a national framework and operational guidance to deliver improved outcomes in all-age autism assessment pathways. It has published national guidance on meeting the needs of autistic adults in mental health services and, to address physical health inequalities, is currently testing a combined health check in primary care for autistic people, those with a severe mental health condition and/or those people with a learning disability.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to publish national dementia outcomes for neighbourhood health services requiring integrated care boards to demonstrate timely access to specialist, community-based dementia support.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
In developing the Modern Service Framework for Frailty and Dementia, we are engaging with a wide group of partners to understand what should be included to ensure the best outcomes for people living with dementia. As part of this exercise, we are considering all options to help reduce variation, including reviewing metrics and targets.
The Neighbourhood Health Service will be the driving force behind our new Genomics Population Health Service; and data will increasingly allow Neighbourhood Health Services to deliver genuinely predictive and pre-emptive care, transforming our care model entirely.
NHS England already collect and publish data about people with dementia at each general practice in England, to enable National Health Service general practitioners and commissioners to make informed choices about how to plan their dementia services around patients’ needs.
The Office for Health Improvement and Disparities Dementia Intelligence Network has also developed a tool for local systems, which includes an assessment of population characteristics such as rurality and socio-economic deprivation. This enables systems to investigate local variation in diagnosis and take informed action to enhance their diagnosis rates. The tool is available via the NHS Futures Collaboration platform.